These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 1703487)

  • 1. Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta.
    Arbogast LA; Voogt JL
    Endocrinology; 1991 Feb; 128(2):997-1005. PubMed ID: 1703487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny of tyrosine hydroxylase mRNA signal levels in central dopaminergic neurons: development of a gender difference in the arcuate nuclei.
    Arbogast LA; Voogt JL
    Brain Res Dev Brain Res; 1991 Nov; 63(1-2):151-61. PubMed ID: 1686424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of tyrosine hydroxylase regulation during pregnancy: evidence for protein dephosphorylation during the prolactin surges.
    Arbogast LA; Voogt JL
    Endocrinology; 1991 Nov; 129(5):2575-82. PubMed ID: 1682138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The responsiveness of tuberoinfundibular dopaminergic neurons to prolactin feedback is diminished between early lactation and midlactation in the rat.
    Arbogast LA; Voogt JL
    Endocrinology; 1996 Jan; 137(1):47-54. PubMed ID: 8536641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trophoblast-specific factor(s) suppresses circulating prolactin levels and increases tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons.
    Arbogast LA; Soares MJ; Tomogane H; Voogt JL
    Endocrinology; 1992 Jul; 131(1):105-13. PubMed ID: 1351837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone suppresses tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nucleus on proestrus.
    Arbogast LA; Voogt JL
    Endocrinology; 1994 Jul; 135(1):343-50. PubMed ID: 7912184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats.
    MohanKumar PS; MohanKumar SM; Quadri SK; Voogt JL
    J Neuroendocrinol; 2001 Mar; 13(3):261-9. PubMed ID: 11207940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central administration of serotonin decreases tyrosine hydroxylase catalytic activity and messenger ribonucleic Acid signal levels in the hypothalamus of female rats.
    Mathiasen JR; Arbogast LA; Voogt JL
    J Neuroendocrinol; 1992 Oct; 4(5):631-9. PubMed ID: 21554649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia.
    Arita J; Kimura F
    Endocrinology; 1986 Oct; 119(4):1666-72. PubMed ID: 3019639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone reverses the estradiol-induced decrease in tyrosine hydroxylase mRNA levels in the arcuate nucleus.
    Arbogast LA; Voogt JL
    Neuroendocrinology; 1993 Nov; 58(5):501-10. PubMed ID: 7906870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressed tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic system during lactation.
    Wang HJ; Hoffman GE; Smith MS
    Endocrinology; 1993 Oct; 133(4):1657-63. PubMed ID: 8104777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine hydroxylase mRNA in the neurons of the tuberoinfundibular region and zona incerta examined after gonadal steroid hormone treatment.
    Morrell JI; Rosenthal MF; McCabe JT; Harrington CA; Chikaraishi DM; Pfaff DW
    Mol Endocrinol; 1989 Sep; 3(9):1426-33. PubMed ID: 2575219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic dopaminergic neurons in transgenic dwarf mice: histofluorescence, immunocytochemical, and in situ hybridization studies.
    Phelps CJ; Carlson S; Hurley DL
    Anat Rec; 1991 Dec; 231(4):446-56. PubMed ID: 1686535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous opioid peptides contribute to suckling-induced prolactin release by suppressing tyrosine hydroxylase activity and messenger ribonucleic acid levels in tuberoinfundibular dopaminergic neurons.
    Arbogast LA; Voogt JL
    Endocrinology; 1998 Jun; 139(6):2857-62. PubMed ID: 9607794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feedback effects of placental lactogens on prolactin levels and Fos-related antigen immunoreactivity of tuberoinfundibular dopaminergic neurons in the arcuate nucleus during pregnancy in the rat.
    Lee Y; Voogt JL
    Endocrinology; 1999 May; 140(5):2159-66. PubMed ID: 10218967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin replacement during development prevents the dopaminergic deficit in hypothalamic arcuate nucleus in prolactin-deficient Ames dwarf mice.
    Romero MI; Phelps CJ
    Endocrinology; 1993 Oct; 133(4):1860-70. PubMed ID: 8104778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid regulation of tyrosine hydroxylase messenger ribonucleic acid in dopaminergic subpopulations of monkey hypothalamus.
    Kohama SG; Bethea CL
    Endocrinology; 1995 Apr; 136(4):1790-800. PubMed ID: 7895692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide (PACAP) increases prolactin release and tuberoinfundibular dopaminergic neuronal activity.
    Arbogast LA; Voogt JL
    Brain Res; 1994 Aug; 655(1-2):17-24. PubMed ID: 7812770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoprolactinemia decreases tyrosine hydroxylase activity in the tuberoinfundibular dopaminergic neurons acutely by protein dephosphorylation and chronically by changes in gene expression.
    Arbogast LA; Voogt JL
    Endocrine; 1995 Nov; 3(11):801-6. PubMed ID: 21153124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular inhibition of tyrosine hydroxylase expression in tuberoinfundibular and nigrostriatal dopaminergic neurons.
    Aguila-Mansilla N; Kedzierski W; Porter JC
    Endocrinology; 1991 Aug; 129(2):877-82. PubMed ID: 1677330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.